Brief: Eliem Therapeutics Q2 operating expenses USD 56.372 million

Climb Bio

14/08/2024 11:24

Aug 14 (Reuters) - Eliem Therapeutics Q2 income from operations USD -56.372
million.
* Q2 net income USD -54.889 million
* Q2 operating expenses USD 56.372 million